Biotech Currents
Subscribe
Sign in
Share this post
Biotech Currents
Data from Merus N.V.’s (MRUS) petosemtamab may be game changer in Head & Neck cancer
Copy link
Facebook
Email
Notes
More
Data from Merus N.V.’s (MRUS) petosemtamab…
Bill Langbein
May 14
Share this post
Biotech Currents
Data from Merus N.V.’s (MRUS) petosemtamab may be game changer in Head & Neck cancer
Copy link
Facebook
Email
Notes
More
Assigning a 69.2% overall probability updated data from Merus will be significantly positive.
Read →
Comments
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
Share this post
Data from Merus N.V.’s (MRUS) petosemtamab…
Share this post
Assigning a 69.2% overall probability updated data from Merus will be significantly positive.